• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清和中枢神经系统组织中的细胞外囊泡在散发性肌萎缩侧索硬化症中含有微小RNA特征。

Extracellular Vesicles in Serum and Central Nervous System Tissues Contain microRNA Signatures in Sporadic Amyotrophic Lateral Sclerosis.

作者信息

Lo Ting-Wen, Figueroa-Romero Claudia, Hur Junguk, Pacut Crystal, Stoll Evan, Spring Calvin, Lewis Rose, Nair Athul, Goutman Stephen A, Sakowski Stacey A, Nagrath Sunitha, Feldman Eva L

机构信息

Department of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States.

Department of Neurology, University of Michigan, Ann Arbor, MI, United States.

出版信息

Front Mol Neurosci. 2021 Oct 29;14:739016. doi: 10.3389/fnmol.2021.739016. eCollection 2021.

DOI:10.3389/fnmol.2021.739016
PMID:34776863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8586523/
Abstract

Amyotrophic lateral sclerosis (ALS) is a terminalneurodegenerative disease. Clinical and molecular observations suggest that ALS pathology originates at a single site and spreads in an organized and prion-like manner, possibly driven by extracellular vesicles. Extracellular vesicles (EVs) transfer cargo molecules associated with ALS pathogenesis, such as misfolded and aggregated proteins and dysregulated microRNAs (miRNAs). However, it is poorly understood whether altered levels of circulating extracellular vesicles or their cargo components reflect pathological signatures of the disease. In this study, we used immuno-affinity-based microfluidic technology, electron microscopy, and NanoString miRNA profiling to isolate and characterize extracellular vesicles and their miRNA cargo from frontal cortex, spinal cord, and serum of sporadic ALS ( = 15) and healthy control ( = 16) participants. We found larger extracellular vesicles in ALS spinal cord versus controls and smaller sized vesicles in ALS serum. However, there were no changes in the number of extracellular vesicles between cases and controls across any tissues. Characterization of extracellular vesicle-derived miRNA cargo in ALS compared to controls identified significantly altered miRNA levels in all tissues; miRNAs were reduced in ALS frontal cortex and spinal cord and increased in serum. Two miRNAs were dysregulated in all three tissues: miR-342-3p was increased in ALS, and miR-1254 was reduced in ALS. Additional miRNAs overlapping across two tissues included miR-587, miR-298, miR-4443, and miR-450a-2-3p. Predicted targets and pathways associated with the dysregulated miRNAs across the ALS tissues were associated with common biological pathways altered in neurodegeneration, including axon guidance and long-term potentiation. A predicted target of one identified miRNA (N-deacetylase and N-sulfotransferase 4; NDST4) was likewise dysregulated in an model of ALS, verifying potential biological relevance. Together, these findings demonstrate that circulating extracellular vesicle miRNA cargo mirror those of the central nervous system disease state in ALS, and thereby offer insight into possible pathogenic factors and diagnostic opportunities.

摘要

肌萎缩侧索硬化症(ALS)是一种晚期神经退行性疾病。临床和分子观察表明,ALS病理起源于单一部位,并以有组织的、朊病毒样的方式传播,可能由细胞外囊泡驱动。细胞外囊泡(EVs)转运与ALS发病机制相关的货物分子,如错误折叠和聚集的蛋白质以及失调的微小RNA(miRNAs)。然而,循环细胞外囊泡或其货物成分水平的改变是否反映该疾病的病理特征,目前尚不清楚。在本研究中,我们使用基于免疫亲和的微流控技术、电子显微镜和NanoString miRNA分析,从散发性ALS患者(n = 15)和健康对照者(n = 16)的额叶皮质、脊髓和血清中分离并表征细胞外囊泡及其miRNA货物。我们发现,与对照组相比,ALS脊髓中的细胞外囊泡更大,而ALS血清中的囊泡尺寸更小。然而,在任何组织中,病例组和对照组之间细胞外囊泡的数量均无变化。与对照组相比,对ALS中细胞外囊泡衍生的miRNA货物进行表征发现,所有组织中的miRNA水平均有显著改变;ALS额叶皮质和脊髓中的miRNAs减少,而血清中的miRNAs增加。有两种miRNAs在所有三个组织中均失调:ALS中miR-342-3p增加,而ALS中miR-1254减少。在两个组织中重叠的其他miRNAs包括miR-587、miR-298、miR-4443和miR-450a-2-3p。与ALS组织中失调的miRNAs相关的预测靶点和途径与神经退行性变中改变的常见生物学途径相关,包括轴突导向和长时程增强。一种已鉴定的miRNA(N-脱乙酰酶和N-磺基转移酶4;NDST4)的预测靶点在ALS的动物模型中同样失调,证实了其潜在的生物学相关性。总之,这些发现表明,循环细胞外囊泡miRNA货物反映了ALS中枢神经系统疾病状态的情况,从而为可能的致病因素和诊断机会提供了见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/5d65fd1d2697/fnmol-14-739016-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/37150d09e047/fnmol-14-739016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/4f10b0c20e00/fnmol-14-739016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/bd17b1ccebab/fnmol-14-739016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/ccbeb3a43e4e/fnmol-14-739016-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/5d65fd1d2697/fnmol-14-739016-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/37150d09e047/fnmol-14-739016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/4f10b0c20e00/fnmol-14-739016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/bd17b1ccebab/fnmol-14-739016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/ccbeb3a43e4e/fnmol-14-739016-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a119/8586523/5d65fd1d2697/fnmol-14-739016-g005.jpg

相似文献

1
Extracellular Vesicles in Serum and Central Nervous System Tissues Contain microRNA Signatures in Sporadic Amyotrophic Lateral Sclerosis.血清和中枢神经系统组织中的细胞外囊泡在散发性肌萎缩侧索硬化症中含有微小RNA特征。
Front Mol Neurosci. 2021 Oct 29;14:739016. doi: 10.3389/fnmol.2021.739016. eCollection 2021.
2
Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.从肌萎缩侧索硬化症患者的细胞外囊泡中鉴定出循环 miRNA 特征。
Brain Res. 2019 Apr 1;1708:100-108. doi: 10.1016/j.brainres.2018.12.016. Epub 2018 Dec 12.
3
Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS.星形胶质细胞来源的细胞外囊泡分泌的 microRNAs 导致 C9orf72 ALS 中的神经元网络退化。
EBioMedicine. 2019 Feb;40:626-635. doi: 10.1016/j.ebiom.2018.11.067. Epub 2019 Jan 31.
4
Current progress in microRNA profiling of circulating extracellular vesicles in amyotrophic lateral sclerosis: A systematic review.肌萎缩侧索硬化症中循环细胞外囊泡的 microRNA 谱分析的研究进展:系统综述。
Neurobiol Dis. 2024 Oct 1;200:106639. doi: 10.1016/j.nbd.2024.106639. Epub 2024 Aug 19.
5
Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels.肌萎缩侧索硬化症中微小 RNA 表达谱的改变:在 NFL mRNA 水平调节中的作用。
Mol Brain. 2013 May 24;6:26. doi: 10.1186/1756-6606-6-26.
6
Assessment of diagnostic potential of some circulating microRNAs in Amyotrophic Lateral Sclerosis Patients, an Egyptian study.评估一些循环 microRNAs 在肌萎缩侧索硬化症患者中的诊断潜力,埃及研究。
Clin Neurol Neurosurg. 2021 Sep;208:106883. doi: 10.1016/j.clineuro.2021.106883. Epub 2021 Aug 10.
7
Serum microRNAs in sporadic amyotrophic lateral sclerosis.散发性肌萎缩侧索硬化症中的血清微小核糖核酸
Neurobiol Aging. 2015 Sep;36(9):2660.e15-20. doi: 10.1016/j.neurobiolaging.2015.06.003. Epub 2015 Jun 9.
8
Wide-Ranging Analysis of MicroRNA Profiles in Sporadic Amyotrophic Lateral Sclerosis Using Next-Generation Sequencing.使用下一代测序技术对散发性肌萎缩侧索硬化症中微小RNA谱进行广泛分析。
Front Genet. 2018 Aug 14;9:310. doi: 10.3389/fgene.2018.00310. eCollection 2018.
9
Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis.全基因组循环 microRNA 表达谱分析揭示肌萎缩侧索硬化症的潜在生物标志物。
Neurobiol Aging. 2018 Apr;64:123-138. doi: 10.1016/j.neurobiolaging.2017.12.020. Epub 2017 Dec 29.
10
MicroRNA expression profiles of neuron-derived extracellular vesicles in plasma from patients with amyotrophic lateral sclerosis.肌萎缩侧索硬化症患者血浆中神经元来源的细胞外囊泡的 microRNA 表达谱。
Neurosci Lett. 2019 Aug 24;708:134176. doi: 10.1016/j.neulet.2019.03.048. Epub 2019 Jun 4.

引用本文的文献

1
miRNAs in neurodegenerative diseases: from target screening to precision therapy.神经退行性疾病中的微小RNA:从靶点筛选到精准治疗
Neurol Sci. 2025 Jun;46(6):2393-2399. doi: 10.1007/s10072-025-08051-8. Epub 2025 Feb 19.
2
Circulating GLAST EVs are increased in amyotrophic lateral sclerosis.在肌萎缩侧索硬化症中,循环中的谷氨酸天冬氨酸转运体(GLAST)细胞外囊泡会增加。
Front Mol Biosci. 2024 Nov 21;11:1507498. doi: 10.3389/fmolb.2024.1507498. eCollection 2024.
3
Shared and distinct changes in the molecular cargo of extracellular vesicles in different neurodegenerative diseases.

本文引用的文献

1
News about the Role of Fluid and Imaging Biomarkers in Neurodegenerative Diseases.关于液体和影像生物标志物在神经退行性疾病中作用的新闻。
Biomedicines. 2021 Mar 4;9(3):252. doi: 10.3390/biomedicines9030252.
2
BMP/TGF-β signaling as a modulator of neurodegeneration in ALS.BMP/TGF-β 信号作为 ALS 神经退行性变的调节剂。
Dev Dyn. 2022 Jan;251(1):10-25. doi: 10.1002/dvdy.333. Epub 2021 Mar 29.
3
Recent advances in understanding amyotrophic lateral sclerosis and emerging therapies.肌萎缩侧索硬化症认识的最新进展及新兴疗法
不同神经退行性疾病中细胞外囊泡分子货物的共同和独特变化。
Cell Mol Life Sci. 2024 Dec 3;81(1):479. doi: 10.1007/s00018-024-05522-7.
4
A microRNA diagnostic biomarker for amyotrophic lateral sclerosis.一种用于肌萎缩侧索硬化症的微小RNA诊断生物标志物。
Brain Commun. 2024 Sep 13;6(5):fcae268. doi: 10.1093/braincomms/fcae268. eCollection 2024.
5
The Neuromuscular Disorder Mediated by Extracellular Vesicles in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症中细胞外囊泡介导的神经肌肉疾病
Curr Issues Mol Biol. 2024 Jun 14;46(6):5999-6017. doi: 10.3390/cimb46060358.
6
Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions.细胞外囊泡作为用于靶向神经系统疾病干预的纳米诊疗平台
Nano Converg. 2024 May 13;11(1):19. doi: 10.1186/s40580-024-00426-5.
7
Exosomes for neurodegenerative diseases: diagnosis and targeted therapy.外泌体在神经退行性疾病中的应用:诊断与靶向治疗。
J Neurol. 2024 Jun;271(6):3050-3062. doi: 10.1007/s00415-024-12329-w. Epub 2024 Apr 12.
8
Lipidic Nanoparticles, Extracellular Vesicles and Hybrid Platforms as Advanced Medicinal Products: Future Therapeutic Prospects for Neurodegenerative Diseases.脂质纳米颗粒、细胞外囊泡和混合平台作为先进医药产品:神经退行性疾病的未来治疗前景
Pharmaceutics. 2024 Mar 1;16(3):350. doi: 10.3390/pharmaceutics16030350.
9
Blood-based CNS regionally and neuronally enriched extracellular vesicles carrying pTau217 for Alzheimer's disease diagnosis and differential diagnosis.用于阿尔茨海默病诊断和鉴别诊断的携带 pTau217 的基于血液的中枢神经系统区域和神经元丰富的细胞外囊泡。
Acta Neuropathol Commun. 2024 Mar 5;12(1):38. doi: 10.1186/s40478-024-01727-w.
10
Attenuation of amyotrophic lateral sclerosis via stem cell and extracellular vesicle therapy: An updated review.通过干细胞和细胞外囊泡疗法减轻肌萎缩侧索硬化症:最新综述
Neuroprotection. 2023 Dec;1(2):130-138. doi: 10.1002/nep3.26. Epub 2023 Nov 20.
Fac Rev. 2020 Nov 17;9:12. doi: 10.12703/b/9-12. eCollection 2020.
4
Emerging role of microRNAs in the pathogenesis of amyotrophic lateral sclerosis.微小 RNA 在肌萎缩侧索硬化症发病机制中的新作用。
Metab Brain Dis. 2021 Jun;36(5):737-749. doi: 10.1007/s11011-021-00697-5. Epub 2021 Feb 19.
5
Fine Particle Exposure and Clinical Aggravation in Neurodegenerative Diseases in New York State.纽约州神经退行性疾病中的细颗粒物暴露与临床恶化。
Environ Health Perspect. 2021 Feb;129(2):27003. doi: 10.1289/EHP7425. Epub 2021 Feb 8.
6
Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises.肌萎缩侧索硬化症:蛋白质、蛋白质稳态、朊病毒与前景
Front Cell Neurosci. 2020 Nov 4;14:581907. doi: 10.3389/fncel.2020.581907. eCollection 2020.
7
Identification of microRNAs enriched in exosomes in human pericardial fluid of patients with atrial fibrillation based on bioinformatic analysis.基于生物信息学分析鉴定心房颤动患者心包积液中外泌体中富集的微小RNA
J Thorac Dis. 2020 Oct;12(10):5617-5627. doi: 10.21037/jtd-20-2066.
8
Tetraspanins, More than Markers of Extracellular Vesicles in Reproduction.四跨膜蛋白家族,不仅仅是生殖细胞外囊泡的标志物。
Int J Mol Sci. 2020 Oct 14;21(20):7568. doi: 10.3390/ijms21207568.
9
MicroRNAs in amyotrophic lateral sclerosis: from pathogenetic involvement to diagnostic biomarker and therapeutic agent development.微小 RNA 在肌萎缩性侧索硬化症中的作用:从发病机制到诊断生物标志物和治疗药物的开发。
Neurol Sci. 2020 Dec;41(12):3569-3577. doi: 10.1007/s10072-020-04773-z. Epub 2020 Oct 1.
10
CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis.脑脊液细胞外囊泡蛋白质组学显示肌萎缩侧索硬化症中蛋白质稳态发生改变。
Clin Proteomics. 2020 Aug 17;17:31. doi: 10.1186/s12014-020-09294-7. eCollection 2020.